Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y P Song

Showing results (51-60 of 134) with videos related to

Pageof 14
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 28, 2020
[Chronic myelogenous leukemia in children complicated with retroperitoneal fibrosis: a case report]Z Li, Yanli Zhang, J Zhou, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 17, 2017
[Expression of IL-37 in peripheral blood of adults with primary immune thrombocytopenia]L Liu, K Feng, M L Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 26, 2019
[Ibrutinib combined with CAR-T cells in the treatment of del (17p) chronic lymphocytic leukemia with BCL-2 inhibitor resistance: a case report and literature review]J J Gong, Q S Yin, M J Li, et al.
Zhonghua Nei Ke Za Zhi|August 10, 2017
[The clinical safety and efficacy of low dose subcutaneous decitabine in treating acute myeloid leukemia and intermediate- or higer-risk myelodysplastic syndromes in the elderly patients]H Ai, X D Wei, Q S Yin, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 10, 2019
[Post-transplantation lymphoproliferative disorder accompanies acquired hemophilia after haploid hematopoietic stem cell transplantation in a pediatric AML patient: a case report and literature review]X L Jiao, Y Q Wang, H Ai, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 17, 2017
[Study on the expression of TRIP13 mRNA in chronic lymphocytic leukemia B lymphocyte and the molecular mechanism of TRIP13 mediated JVM-2 cell proliferation and apoptosis]K S Zhou, Q Zhang, W T Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 28, 2023
[Targeted immunotherapy efficacy analysis in patients with relapsed/refractory B cell acute lymphocytic leukemia]Y Su, S Bao, Y P Wei, et al.
Zhonghua Nei Ke Za Zhi|October 1, 2016
[The efficacy analysis of interferon combined with imatinib in chronic myelogenous leukemia patients with ABL kinase domain mutations]Y L Zu, Y L Zhang, J Zhou, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 15, 2021
[The involvement of neuropilin-1 in primary immune thrombocytopenia]H Zhou, J Y Yang, P P Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 17, 2017
[Clinical characteristics of HIV-negative plasmablastic lymphoma]J W Du, X Sun, G P Li, et al.
Pageof 14

Showing results (51-60 of 134) with videos related to

Sort By:
Pageof 14
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 28, 2020
[Chronic myelogenous leukemia in children complicated with retroperitoneal fibrosis: a case report]Z Li, Yanli Zhang, J Zhou, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 17, 2017
[Expression of IL-37 in peripheral blood of adults with primary immune thrombocytopenia]L Liu, K Feng, M L Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 26, 2019
[Ibrutinib combined with CAR-T cells in the treatment of del (17p) chronic lymphocytic leukemia with BCL-2 inhibitor resistance: a case report and literature review]J J Gong, Q S Yin, M J Li, et al.
Zhonghua Nei Ke Za Zhi|August 10, 2017
[The clinical safety and efficacy of low dose subcutaneous decitabine in treating acute myeloid leukemia and intermediate- or higer-risk myelodysplastic syndromes in the elderly patients]H Ai, X D Wei, Q S Yin, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 10, 2019
[Post-transplantation lymphoproliferative disorder accompanies acquired hemophilia after haploid hematopoietic stem cell transplantation in a pediatric AML patient: a case report and literature review]X L Jiao, Y Q Wang, H Ai, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 17, 2017
[Study on the expression of TRIP13 mRNA in chronic lymphocytic leukemia B lymphocyte and the molecular mechanism of TRIP13 mediated JVM-2 cell proliferation and apoptosis]K S Zhou, Q Zhang, W T Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 28, 2023
[Targeted immunotherapy efficacy analysis in patients with relapsed/refractory B cell acute lymphocytic leukemia]Y Su, S Bao, Y P Wei, et al.
Zhonghua Nei Ke Za Zhi|October 1, 2016
[The efficacy analysis of interferon combined with imatinib in chronic myelogenous leukemia patients with ABL kinase domain mutations]Y L Zu, Y L Zhang, J Zhou, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 15, 2021
[The involvement of neuropilin-1 in primary immune thrombocytopenia]H Zhou, J Y Yang, P P Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 17, 2017
[Clinical characteristics of HIV-negative plasmablastic lymphoma]J W Du, X Sun, G P Li, et al.
Pageof 14